FibroBiologics (FBLG) Assets (2022 - 2026)
FibroBiologics (FBLG) posted quarterly Assets of $7.9 million for Q2 2026, down 42.99% year-over-year from $13.9 million in Q2 2025, and up 33.53% on a QoQ basis from $5.9 million in Q1 2026.
FibroBiologics (FBLG) Assets (2022 - 2026) Analysis & Trends
FibroBiologics has reported Assets for 5 years, with the latest figure at $7.9 million in Q2 2026.
- Assets for Q2 2026 came in at $7.9 million, down 42.99% year-over-year; the trailing twelve-month figure through Jun 2026 was $7.9 million (down 42.99% YoY), and the FY2025 annual result was $9.6 million, down 41.51% from the prior year.
- Assets grew to $7.9 million in Q2 2026, from $5.9 million in the prior quarter.
- Over five years, Assets peaked at $16.4 million in Q4 2024 and troughed at $4.8 million in Q4 2022.
- A 5-year average of $10.1 million and a median of $10.0 million in 2024 frame the typical range for Assets.
- The widest annual swing landed in 2023, when Assets soared 145.05%; it then slumped 48.03% in 2026.
- A 5-year view of Assets shows it stood at $4.8 million in 2022, then soared by 145.05% to $11.8 million in 2023, then surged by 39.12% to $16.4 million in 2024, then tumbled by 41.51% to $9.6 million in 2025, then decreased by 17.57% to $7.9 million in 2026.
- Per Business Quant data, the three most recent Assets figures were $7.9 million in Q2 2026, $5.9 million in Q1 2026, and $9.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | FibroBiologics | 8.97 Mn | 8.97 Mn | - | 7.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.93 Mn |
| Mar 31, 2026 | 5.94 Mn |
| Dec 31, 2025 | 9.62 Mn |
| Sep 30, 2025 | 8.74 Mn |
| Jun 30, 2025 | 13.91 Mn |
| Mar 31, 2025 | 11.43 Mn |
| Dec 31, 2024 | 16.45 Mn |
| Sep 30, 2024 | 10.47 Mn |
| Jun 30, 2024 | 8.91 Mn |
| Mar 31, 2024 | 11.40 Mn |
| Dec 31, 2023 | 11.82 Mn |
| Dec 31, 2022 | 4.82 Mn |